SCHEMBL19636634

SCHEMBL19636634

Cn1cc(NC(=O)c2csc(NC(C)(C)C)n2)cc1C(=O)Nc1cc(C(=O)C(C)(C)C)n(C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRAS P01112 3/20 0.36
▸ ESR1 P03372 3/20 0.36
▸ ESR2 Q92731 3/20 0.36
▸ DHFR P00374 3/20 0.36
▸ EGFR P00533 3/20 0.36
▸ TOP1 P11387 2/20 0.36
▸ POLB P06746 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ PIK3CG P48736 1/20 0.35
▸ HPSE Q9Y251 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ PKM P14618 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CLK1 P49759 2/20 0.33
▸ CLK4 Q9HAZ1 2/20 0.33
▸ DYRK3 O43781 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19636638 0.98 PIK3CG (0.37) HRASESR1ESR2DHFREGFR
SCHEMBL19636637 0.82 TOP1 (0.41) HRASESR1ESR2TOP1POLB
SCHEMBL19636636 0.79 DHFR (0.40) HRASESR1ESR2DHFREGFR
SCHEMBL19636924 0.79 DHFR (0.40) HRASESR1ESR2DHFREGFR
SCHEMBL26440477 0.78 HDAC1 (0.45) HRASESR1ESR2TOP1POLB
SCHEMBL3939239 0.76 ABCB1 (0.41) DHFREGFRPOLBNPC1RAB9A
SCHEMBL20796574 0.75 HDAC1 (0.42) HRASESR1ESR2TOP1POLB
SCHEMBL3933864 0.75 ABCB1 (0.49) EGFRPOLBKDM4EMAPTNPC1
SCHEMBL19614881 0.74 ABCB1 (0.42) DHFREGFRL3MBTL1CHEK1
SCHEMBL10110767 0.74 AR (0.35) HRASESR1ESR2TOP1HPSE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10660901-B2 Pyrrolobenzodiazepines and conjugates thereof MERSANA THERAPEUTICS, INC. (US) 2020-05-26 — — US disclosed
US-20190070194-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF MERSANA THERAPEUTICS, INC. 2019-03-07 — — US disclosed
US-20170333442-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF MERSANA THERAPEUTICS, INC. 2017-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170333442-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF CD79B, CLTB, FCGR3B HRAS 2022/4885ESR1 3334/4885ESR2 3612/4885
US-20190070194-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF CD79B, CLTB, FCGR3B HRAS 2022/4885ESR1 3334/4885ESR2 3612/4885
US-10660901-B2 Pyrrolobenzodiazepines and conjugates thereof CD79B, CLTB, FCGR3B HRAS 2022/4885ESR1 3334/4885ESR2 3612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback